Created at	Source	Raw Value	Validated value
June 25, 2024, noon	usa	* moderate, severe and critical covid-19 * day 0 crp greater than 6mg/dl, alc \< 1000 or evidence of infiltrates on x-ray chest * comorbidity with life expectancy less than 6 months * contraindications to hcq therapy	* moderate, severe and critical covid-19 * day 0 crp greater than 6mg/dl, alc \< 1000 or evidence of infiltrates on x-ray chest * comorbidity with life expectancy less than 6 months * contraindications to hcq therapy
Oct. 26, 2020, 11:31 p.m.	usa	- moderate, severe and critical covid-19 - day 0 crp greater than 6mg/dl, alc < 1000 or evidence of infiltrates on x-ray chest - comorbidity with life expectancy less than 6 months - contraindications to hcq therapy	- moderate, severe and critical covid-19 - day 0 crp greater than 6mg/dl, alc < 1000 or evidence of infiltrates on x-ray chest - comorbidity with life expectancy less than 6 months - contraindications to hcq therapy